Mathieu Coudert

1.6k total citations
39 papers, 823 citations indexed

About

Mathieu Coudert is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mathieu Coudert has authored 39 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mathieu Coudert's work include Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Mathieu Coudert is often cited by papers focused on Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Mathieu Coudert collaborates with scholars based in France, United Kingdom and United States. Mathieu Coudert's co-authors include Lital Hollander, Michael Weigel, Jeanine Ohl, Juliette Guibert, Pietro Vernazza, Carole Gilling‐Smith, Louis Bujan, A.E. Semprini, Yvon Englert and Paul Delmar and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Mathieu Coudert

38 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathieu Coudert France	15	234	118	112	108	105	39	823
Luis A. Rodríguez United States	20	170 0.7×	33 0.3×	114 1.0×	63 0.6×	87 0.8×	42	1.1k
Karen H. van Hoeven United States	19	174 0.7×	34 0.3×	221 2.0×	138 1.3×	163 1.6×	51	1.5k
Joris Diels Belgium	19	98 0.4×	19 0.2×	218 1.9×	93 0.9×	224 2.1×	113	1.1k
Fady Hannah‐Shmouni United States	18	499 2.1×	107 0.9×	132 1.2×	22 0.2×	62 0.6×	85	1.2k
C. H. Darby United States	9	196 0.8×	22 0.2×	104 0.9×	52 0.5×	124 1.2×	21	962
Courtney Gray‐McGuire United States	20	210 0.9×	14 0.1×	73 0.7×	135 1.3×	191 1.8×	33	1.4k
Lisa Shah United States	15	57 0.2×	49 0.4×	195 1.7×	18 0.2×	65 0.6×	45	899
Mary Woods United Kingdom	14	55 0.2×	20 0.2×	356 3.2×	98 0.9×	116 1.1×	41	1.0k
Fu‐Sung Lo Taiwan	17	330 1.4×	25 0.2×	44 0.4×	30 0.3×	31 0.3×	85	916
Fernando Franco Spain	14	52 0.2×	30 0.3×	305 2.7×	39 0.4×	211 2.0×	44	803

Countries citing papers authored by Mathieu Coudert

Since Specialization

Citations

This map shows the geographic impact of Mathieu Coudert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Coudert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Coudert more than expected).

Fields of papers citing papers by Mathieu Coudert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Coudert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Coudert. The network helps show where Mathieu Coudert may publish in the future.

Co-authorship network of co-authors of Mathieu Coudert

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Coudert. A scholar is included among the top collaborators of Mathieu Coudert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Coudert. Mathieu Coudert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hassanein, Mohamed, Rachid Malek, Inass Shaltout, et al.. (2023). Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(2). 102707–102707. 10 indexed citations

Battelino, Tadej, Thomas Danne, Steve Edelman, et al.. (2022). C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial. Diabetes Obesity and Metabolism. 25(2). 545–555. 20 indexed citations

Anderson, John E., et al.. (2020). Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control. Journal of Diabetes and its Complications. 35(4). 107831–107831. 3 indexed citations

Sahay, Rakesh, Khadija Hafidh, Mathieu Coudert, et al.. (2020). Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial. Diabetes Research and Clinical Practice. 163. 108148–108148. 7 indexed citations

Debieuvre, D., L. Moreau, Mathieu Coudert, et al.. (2019). Erlotinib en 2e ou 3e ligne pour les cancers bronchiques non à petites cellules sans mutation de l’EGFR : données en vie réelle. Revue des Maladies Respiratoires. 36(6). 649–663. 1 indexed citations

Martina, Reynaldo, Paul Delmar, Mathieu Coudert, et al.. (2017). Retrospective indirect comparison of alectinib phase II data vs ceritinib real-world data in ALK+ NSCLC after progression on crizotinib. Annals of Oncology. 28. ii36–ii36. 3 indexed citations

Flipo, René‐Marc, et al.. (2017). Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study. RMD Open. 3(1). e000340–e000340. 8 indexed citations

Coudert, Mathieu, et al.. (2016). Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients. Value in Health. 19(7). A765–A765. 3 indexed citations

Coudert, Bruno, Jean‐Yves Pierga, Marie‐Ange Mouret‐Reynier, et al.. (2014). Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial. The Lancet Oncology. 15(13). 1493–1502. 97 indexed citations

10.

Michelon, Hugues, et al.. (2014). Generic drugs at hospital discharge: assessment in geriatrics. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 12(1). 13–19. 1 indexed citations

11.

Nazac, André, Angelo Pierangelo, Marie‐Noël Vercambre, et al.. (2013). Étude prospective comparant les performances de la colposcopie classique à la colposcopie guidée par polarimétrie sur la détection des néoplasies intra-épithéliales du col utérin. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 42(5). 464–472. 1 indexed citations

12.

Mercadal, Lucile, Mathieu Coudert, Anne Vassault, et al.. (2012). L-Carnitine Treatment in Incident Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 7(11). 1836–1842. 26 indexed citations

13.

Bachelot, Anne, Zeina Chakhtoura, Geneviève Plu‐Bureau, et al.. (2012). Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia. European Journal of Endocrinology. 167(4). 499–505. 31 indexed citations

14.

Gautier, Alain, Ariane Godbout, Mathieu Coudert, et al.. (2012). Markers of Recurrence and Long-Term Morbidity in Craniopharyngioma: A Systematic Analysis of 171 Patients. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1258–1267. 91 indexed citations

15.

Berlin, Ivan, et al.. (2010). Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial—a randomized study in smokers with medical comorbidities. Addiction. 106(4). 833–843. 20 indexed citations

16.

Coudert, Mathieu, et al.. (2010). Effect of the threat of a disulfiram–ethanol reaction on cue reactivity in alcoholics. Drug and Alcohol Dependence. 112(3). 239–246. 11 indexed citations

17.

Morin, Nathalie, et al.. (2009). Impact of antiphosholipid biology in maternal Down syndrome screening. Prenatal Diagnosis. 29(5). 481–488. 5 indexed citations

18.

Baatz, H., Lucie Poupel, Mathieu Coudert, Florian Sennlaub, & Christophe Combadière. (2009). Komplementfaktor-Polymorphismen und altersassoziierte Makuladegeneration in einer Gruppe deutscher Patienten. Klinische Monatsblätter für Augenheilkunde. 226(8). 654–658. 4 indexed citations

19.

Soria, Claudine, Claire Bal dit Sollier, Jeanne‐Yvonne Borg, et al.. (2009). Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level. Thrombosis and Haemostasis. 102(7). 131–136. 7 indexed citations

20.

Jublanc, Christel, et al.. (2008). Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients. Atherosclerosis. 203(1). 269–276. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact